Stay updated on Dupilumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Chronic Urticaria Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:25:59.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:01:18.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T21:50:22.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the previously visible study record details for NCT03749135. This indicates the study information is temporarily inaccessible due to an access restriction or site issue.
    Difference
    18%
    Check dated 2026-09-20T20:40:42.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Added a funding note for 2017 (NIH grant/contract) in the study identifiers and updated the page revision from v3.6.5 to v3.6.6, reflecting new funding information and the current document version.
    Difference
    0.1%
    Check dated 2026-08-30T21:41:16.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.5 replacing Revision: v3.6.4, indicating a small site revision. The update does not alter the study information or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-08-09T09:13:46.000Z thumbnail image

Stay in the know with updates to Dupilumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.